Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation

<div>Evaluation of inflammation-related molecules in CKD-G5D patients. CKD-G5D patients were classified into two groups according to the presence of diabetes mellitus (DM). CRP (a), PTX3 (b), and TNF<i>α</i> (c) levels were compared between DM and non-DM groups. No statistically significant differences were observed between the two groups.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation 

Figure 2 | Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation 